Back to Search
Start Over
Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM)--added trial
- Source :
- American Heart Journal. May, 2006, Vol. 151 Issue 5, p985, 7 p.
- Publication Year :
- 2006
Details
- Language :
- English
- ISSN :
- 00028703
- Volume :
- 151
- Issue :
- 5
- Database :
- Gale General OneFile
- Journal :
- American Heart Journal
- Publication Type :
- Academic Journal
- Accession number :
- edsgcl.152895568